Skip to main content
Find more clinical trials

Light and Cognitive Therapy for Alzheimer's Disease

Start: January 1, 2018
End: December 31, 2023
Enrollment: 2000

What Is This Study About?

Electrical activity in the brain known as gamma brainwaves helps connect and process information throughout the brain. Research suggests that exposure to a light flickering at 40 Hz may promote gamma-wave brain activity, which could potentially activate cells in the brain to eliminate beta-amyloid plaques that are common in Alzheimer's disease. This one-year observational study will test the ability of an iPad application, also called an app, to improve cognition, function, and quality of life in people with Alzheimer's disease. Participants will use the iPad app on a daily basis to play cognitive games (e.g., Sudoku, Tic-Tac-Toe) while being exposed to light therapy at 40 Hz. Each month, the participant's caregiver will use the app to report on the participant's functioning in daily living activities.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: N/A

Must have:

  • Alzheimer's disease
  • Cognitive impairment

Must NOT have:

  • Previous epileptic seizures, including febrile seizures
  • Significant disease of the eye, such as macular degeneration
 
Study Contact
Andrey Vyshedskiy, PhD

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Florida
Andrey Vyshedskiy
Miami, FL 33156
Recruiting
Andrey Vyshedskiy

Who Sponsors This Study?

Lead: Alzheimer's Light LLC

Source: ClinicalTrials.gov ID: NCT03657745